Vertex Pharmaceuticals Inc Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 53 trades in Vertex Pharmaceuticals Inc (NASDAQ: VRTX) since 2015, across 18 members, worth an estimated $546.53K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 22 buys against 31 sells, a modestly sell-led skew, with Democratic members responsible for 66% of the trades and Republican members 34%. The most recent disclosure shown was filed February 2026, and David J. Taylor has filed the most VRTX transactions among those shown, with 2. Other recent filers include Lisa Mcclain. One notable disclosed move was a purchase by David J. Taylor on August 7, 2025, up 14.0% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Vertex Pharmaceuticals Inc (VRTX) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Vertex Pharmaceuticals congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | |
|---|---|---|---|---|---|---|---|
 David J. Taylor House | Feb 2, 2026 | Jan 29, 2026 | 4 days | SELL |  $1,001 - $15,000 | -9.95% | |
David J. Taylor House | Sep 2, 2025 | Aug 7, 2025 | 26 days | BUY | $1,001 - $15,000 | +14.03% | |
 Lisa Mcclain House | Aug 13, 2025 | Jun 11, 2025 | 63 days | SELL | $1,001 - $15,000 | -5.33% | |
Lisa Mcclain House | Aug 13, 2025 | Jun 10, 2025 | 64 days | SELL | $1,001 - $15,000 | -5.13% |
Vertex Pharmaceuticals (VRTX) congressional trading FAQ
Can members of Congress legally trade Vertex Pharmaceuticals (VRTX) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Vertex Pharmaceuticals (VRTX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; it does not imply any trade was improper.
Are congressional Vertex Pharmaceuticals (VRTX) trades public?
Yes. Every congressional trade in Vertex Pharmaceuticals (VRTX) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Vertex Pharmaceuticals (VRTX)?
Members of Congress have disclosed 53 trades in Vertex Pharmaceuticals (VRTX) worth $546.53K across 18 members, according to public STOCK Act filings.
Which members of Congress have traded Vertex Pharmaceuticals (VRTX)?
Recent and active filers of Vertex Pharmaceuticals (VRTX) disclosures include David J. Taylor, Lisa Mcclain. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Vertex Pharmaceuticals (VRTX) more?
Across disclosed Vertex Pharmaceuticals (VRTX) trades, 66% were by Democrats and 34% by Republicans, led by Democrats (66%).
What is the most recent congressional Vertex Pharmaceuticals (VRTX) trade?
The most recent disclosed Vertex Pharmaceuticals (VRTX) trade was a sale by David J. Taylor, filed Feb 1, 2026.
Browse all stocks Congress tradesCongressional trading overviewVertex Pharmaceuticals (VRTX) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.